Newly synthesized curcumin analog has improved potential to prevent colorectal carcinogenesis in vivo

Cancer Science

Volumn 100, Issue 5, 2009, Pages 956-960

  Shibata, Hiroyuki ^a   Yamakoshi, Hiroyuki ^a   Sato, Atsuko ^a   Ohori, Hisatsugu ^a   Kakudo, Yuichi ^a   Kudo, Chieko ^a   Takahashi, Yayoi ^b   Watanabe, Mika ^b   Takano, Hiroshi ^c   Ishioka, Chikashi ^a   Noda, Tetsuo ^c   Iwabuchi, Yoshiharu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,5 BIS[3,5(BISMETHOXYMETHOXYPHENYL)PENTA 1,4 DIEN 3 ONE]; ANTINEOPLASTIC AGENT; APC PROTEIN; BETA CATENIN; CURCUMIN DERIVATIVE; GO Y 030; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER SURVIVAL; COLON CARCINOGENESIS; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; GASTROINTESTINAL POLYPOSIS; IN VIVO STUDY; INTESTINE OBSTRUCTION; LIFESPAN; LIVER TOXICITY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURVIVAL TIME;

ADENOMA; ANIMALS; BENZENE DERIVATIVES; BETA CATENIN; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; CURCUMIN; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; KETONES; MICE; MOLECULAR STRUCTURE; SURVIVAL RATE;

EID: 65349175650     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01127.x     Document Type: Article

References (18)

1. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as 'Curecumin': From kitchen to clinic. Biochem Pharmacol 2007; 75: 787-809.
2. Singh YJ, Aggarwal BB. Activation of transcription factor NF-κB is suppressed by curcumin (diferuloymethane). J Biol Chem 1995; 270: 24995-5000.
3. Menon LG, Kuttan R, Kuttan G. Anti-metastatic activity of curcumin and catechin. Cancer Lett 1999; 141: 159-65.
4. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. Synthetic curcumin analogs inhibit activation protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 2004; 321: 337-44.
5. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995; 92: 3046-50.
6. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 1997; 272: 24735-8.
7. Morin PJ, Sparks AB, Korinek V et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-90.
8. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
9. Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
10. Sharma R, Gescher AJ, McLelland HR et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 2001; 7: 1894-900.
11. Ireson CR, Jones DJ, Orr S et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 2002; 11: 105-11.
12. Perkins S, Verschoyle RD, Hill K, Parveen I et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol, Biomarkers Prevention 2002; 11: 535-40.
13. Ohori H, Yamakoshi H, Tomizawa M et al. Synthesis and biological analysis of new curcumin analogs bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther 2006; 5: 2563-71.
14. Mahmoud NN, Carothers AM, Grunberger D et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000; 21: 921-7.
15. Shibata H, Toyama K, Shioya H et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997; 278: 120-3.
16. Shibata H, Takano H, Ito M et al. α-Catenin is essential in intestinal adenoma formation. Proc Natl Acad Sci USA 2007; 104: 18199-204.
17. Oshima H, Oshima M, Kobayashi M, Tsutsumi M, Taketo MM. Morphological and molecular processes of polyp formation in Apc Δ716 knockout mice. Cancer Res 1997; 57: 1644-9.
18. Petrova TV, Nykänen A, Norrmén C et al. Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 2008; 13: 407-19.